Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gut Mucosal Immune Function in HIV on Short-term cART
NCT02097381Unknown
- Sponsor
- Sapienza University of Rome
- Start
- Apr 2010
- Primary completion
- Mar 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label, single-arm trial of tenofovir disoproxil fumarate, emtricitabine, lopinavir, ritonavir and darunavir in human immunodeficiency virus infection (HIV), sponsored by Sapienza University of Rome. Primary endpoint: Difference of number of total Th1 and Th17 CD4+ T-cells in colon samples at 6 months. Status: unknown.
02
Drugs
tenofovir disoproxil fumarateemtricitabinelopinavirritonavirdarunavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02097381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02097381.